Title: Welcome to ImmunoCellular Theraputics, Ltd. (OTC:IMUC.OB)
Description: ImmunoCellular Theraputics, Ltd. (OTC:IMUC.OB) IMUC is a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. The Company recently completed a Phase I trial of its lead product c
Keywords:ImmunoCellular Therapeutics Ltd., IMUC, IMUC.OB, technology, ICT-121, tumor, Cedars-Sinai Medical Center, multiple antigen, dendritic cell, cancer vaccine, stem cell, vaccine technologies, neurodegenerative disorders, Phase I, trial, releases, investor, relations, contact, candidate, team, OTCBB:IMUC, monoclonal antibody-related technology, treat glioblastoma multiforme, Molecular Discoveries LLC.,
... (View More)
B-lymphocytes B-cells, treatment of multiple myeloma, small cell lung, pancreatic and ovarian cancers, Investigational New Drug IND, chemotherapy concomitantly, Maxine Dunitz Neurosurgical Institute at Cedars, American Cancer Society, cancer treatment centers of america, national cancer institute, choosing a treatment program, cancer information, research and treatment options, preclinical model, principle studies demonstrating efficacy, proof-of-principle, ict121, ICT-107, aliva biopharmaceuticals, petricoin(View Less)
